| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pipeline targets Friedreich's Ataxia (FA), a severe, progressive, monogenic, and autosomal recessive disease. FA primarily impairs mitochondrial function across various organ systems, resulting in neurological, cardiac, and metabolic complications. Another significant area of development is Myotonic Dystrophy Type-1 (DM1). This is a progressive, …
Over the last 12 months, insiders at Design Therapeutics, Inc. have bought $0 and sold $0 worth of Design Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Design Therapeutics, Inc. have bought $7.12M and sold $2.24M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 17,809 shares for transaction amount of $66,606 was made by Schmid John P. (director) on 2024‑03‑25.
| 2025-08-13 | Sale | William Arsani | director | 562,627 0.957% | $5.25 | $2.95M | +87.64% | |
| 2024-12-18 | Sale | Prasad Deepa | director | 3,806 0.0073% | $6.27 | $23,864 | -18.32% | |
| 2024-08-09 | Sale | William Arsani | director | 814,874 1.4426% | $4.25 | $3.46M | +11.32% | |
| 2024-03-25 | Schmid John P. | director | 17,809 0.0318% | $3.74 | $66,606 | +27.01% | ||
| 2024-03-25 | Berger Heather A. | director | 1,300 0.0023% | $3.74 | $4,866 | +27.01% | ||
| 2024-03-22 | Schmid John P. | director | 9,156 0.0156% | $3.62 | $33,133 | +25.00% | ||
| 2023-09-29 | LAPPE RODNEY W | director | 21,000 0.0373% | $2.35 | $49,287 | +41.10% | ||
| 2023-08-29 | William Arsani | director | 1.96M 3.6838% | $2.44 | $4.78M | +19.26% | ||
| 2023-08-29 | Prasad Deepa | director | 12,000 0.0213% | $2.31 | $27,670 | +19.26% | ||
| 2023-08-28 | William Arsani | director | 275,000 0.48% | $2.15 | $591,250 | +24.09% | ||
| 2022-12-20 | SR One Capital Fund I Aggregator LP | director | 40,000 0.0725% | $8.14 | $325,432 | -27.67% | ||
| 2022-12-20 | George Simeon | director | 40,000 0.0725% | $8.14 | $325,432 | -27.67% | ||
| 2022-12-20 | Siffert Joao MD | President and CEO | 6,300 0.0118% | $8.38 | $52,763 | -27.67% | ||
| 2022-12-19 | SR One Capital Fund I Aggregator LP | director | 360,000 0.6698% | $8.63 | $3.11M | -29.29% | ||
| 2022-12-19 | George Simeon | director | 360,000 0.6698% | $8.63 | $3.11M | -29.29% | ||
| 2022-12-19 | Siffert Joao MD | President and CEO | 1,150 0.0021% | $8.47 | $9,741 | -29.29% | ||
| 2022-12-16 | SR One Capital Fund I Aggregator LP | director | 500,000 0.8485% | $8.28 | $4.14M | -32.02% | ||
| 2022-12-16 | George Simeon | director | 500,000 0.8485% | $8.28 | $4.14M | -32.02% | ||
| 2022-12-09 | LAPPE RODNEY W | director | 15,000 0.0273% | $7.96 | $119,426 | -21.76% | ||
| 2022-03-21 | William Arsani | 25,000 0.0461% | $18.99 | $474,680 | -22.95% |
| George Simeon | director | 6526476 10.4287% | $67.48M | 4 | 0 | <0.0001% |
| SR One Capital Fund I Aggregator LP | director | 6526476 10.4287% | $67.48M | 4 | 0 | <0.0001% |
| Cormorant Asset Management, LP | 5114844 8.1731% | $52.89M | 1 | 0 | <0.0001% | |
| Xu Stella | 4155405 6.64% | $42.97M | 1 | 1 | <0.0001% | |
| William Arsani | director | 1000000 1.5979% | $10.34M | 5 | 2 | <0.0001% |
| LAPPE RODNEY W | director | 133024 0.2126% | $1.38M | 3 | 0 | +0.06% |
| Siffert Joao MD | President and CEO | 132619 0.2119% | $1.37M | 2 | 0 | |
| Schmid John P. | director | 26965 0.0431% | $278,818.10 | 2 | 0 | +26% |
| Shah Pratik | Executive Chairperson | 25000 0.0399% | $258,500.00 | 1 | 0 | <0.0001% |
| Prasad Deepa | director | 20000 0.032% | $206,800.00 | 1 | 1 | +19.26% |
| Thacker Justin | Vice President, Finance | 17500 0.028% | $180,950.00 | 1 | 0 | <0.0001% |
| Jeffries Sean | Chief Operating Officer | 3050 0.0049% | $31,537.00 | 1 | 0 | <0.0001% |
| Berger Heather A. | director | 1300 0.0021% | $13,442.00 | 1 | 0 | +27.01% |
$10,154,205 | 103 | -4.60% | $631.34M | |
$860,541,348 | 82 | -5.10% | $649.64M | |
$40,226,318 | 58 | 18.89% | $539.26M | |
$1,344,238 | 38 | 23.07% | $639.18M | |
$59,156,363 | 22 | 29.25% | $686.5M |
| Increased Positions | 70 | +75.27% | 9M | +26.79% |
| Decreased Positions | 37 | -39.78% | 6M | -16.25% |
| New Positions | 32 | New | 4M | New |
| Sold Out Positions | 9 | Sold Out | 2M | Sold Out |
| Total Postitions | 126 | +35.48% | 38M | +10.54% |
| Sr One Capital Management, Lp | $59,391.00 | 11.45% | 6.53M | 0 | 0% | 2025-09-30 |
| Logos Global Management Lp | $33,261.00 | 6.41% | 3.65M | -562,627 | -13.34% | 2025-09-30 |
| Point72 Asset Management, L.P. | $30,399.00 | 5.86% | 3.34M | +2M | +84.84% | 2025-09-30 |
| Blackrock, Inc. | $18,604.00 | 3.59% | 2.04M | -351,355 | -14.67% | 2025-09-30 |
| Frazier Life Sciences Management, L.P. | $17,777.00 | 3.43% | 1.95M | 0 | 0% | 2025-09-30 |
| Tang Capital Management Llc | $16,207.00 | 3.13% | 1.78M | 0 | 0% | 2025-09-30 |
| Baker Bros. Advisors Lp | $15,587.00 | 3.01% | 1.71M | 0 | 0% | 2025-09-30 |
| Almitas Capital Llc | $13,927.00 | 2.69% | 1.53M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $13,138.00 | 2.53% | 1.44M | -27,873 | -1.89% | 2025-09-30 |
| Driehaus Capital Management Llc | $9,794.00 | 1.89% | 1.08M | 0 | 0% | 2025-09-30 |